ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,149Medicare Part D Prescriptions Filled, Including Refills

Rank: 332 out of 6645

$1.05M Total Retail Price of All Prescriptions

Rank: 292 out of 6645

675 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 675 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

3% of this provider’s 14,344 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
ALENDRONATE SODIUM 1,305 1,245 1 14
SIMVASTATIN 759 697 2 1
AMLODIPINE BESYLATE 680 641 3 2
LOSARTAN POTASSIUM 648 645 4 12
METFORMIN HCL 466 445 5 7
BENAZEPRIL HCL 463 417 6 21
DIOVAN 429 415 7 19
CRESTOR 400 383 8 34
LOVASTATIN 385 361 9 15
OMEPRAZOLE 375 349 10 6
GLYBURIDE 330 324 R 11 58
ATORVASTATIN CALCIUM 318 298 12 10
ATENOLOL 313 290 13 8
CEPHALEXIN 270 254 14 111
TAMSULOSIN HCL 208 189 15 22
GABAPENTIN 200 189 16 18
ATELVIA 197 190 17 91
LISINOPRIL 189 173 18 3
PATANOL 177 175 19 131
DIOVAN HCT 165 165 20 64
TRIAMCINOLONE ACETONIDE 162 155 21 55
AZITHROMYCIN 160 149 22 44
FLUTICASONE PROPIONATE 159 152 23 26
PROAIR HFA 153 148 24 32
AMOXICILLIN 148 138 25 107
IBUPROFEN 139 127 26 42
SINGULAIR 138 135 27 76
LIPITOR 136 129 28 69
PATADAY 133 130 29 183
FLUOCINONIDE 126 125 30 130
METOPROLOL SUCCINATE 123 120 31 24
LOPERAMIDE 121 119 32 281
ZETIA 120 107 33 87
MELOXICAM 115 115 34 46
ACTONEL 113 94 35 92
TERAZOSIN HCL 111 96 36 48
LOVAZA 107 98 37 68
JANUVIA 102 91 38 38
METOPROLOL TARTRATE 100 98 39 13
COLCRYS 98 96 40 192
ADVAIR DISKUS 98 90 40 45
BENICAR 95 86 42 84
CELEBREX 94 94 43 54
CIPROFLOXACIN HCL 94 82 43 67
HYDROCHLOROTHIAZIDE 90 76 45 9
GLYBURIDE-METFORMIN HCL 85 71 R 46 95
CARVEDILOL 85 83 46 25
GLIMEPIRIDE 82 82 48 47
ONGLYZA 77 77 49 168
AVODART 77 65 49 99
LOSARTAN-HYDROCHLOROTHIAZIDE 76 76 51 62
LEVOTHYROXINE SODIUM 73 61 52 4
FENOFIBRATE 71 63 53 74
TRAVATAN Z 68 64 54 342
RANITIDINE HCL 68 66 54 51
NAPROXEN 67 58 56 88
DICLOFENAC SODIUM 64 62 57 109
SPIRIVA 59 59 58 65
MECLIZINE HCL 59 57 58 122
NIFEDIPINE ER 58 54 60 82
AMOX TR-POTASSIUM CLAVULANATE 57 55 61 185
SYMBICORT 55 47 62 153
PLAVIX 53 51 63 49
MONTELUKAST SODIUM 53 53 63 128
LEVOFLOXACIN 52 52 65 83
ZENPEP 51 51 66 210
COMBIVENT 51 51 66 174
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 6, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.